ctrl K

AI Score

Unlock

NeuroSense Therapeutics L... (NRSN)

AI Score

Unlock

0.92

0.01 (1.23%)

At close: Apr 02, 2025, 3:59 PM

0.91

-1.62%

After-hours: Apr 02, 2025, 05:01 PM EDT

NeuroSense Therapeutics Ltd. Income Statement

Chart Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	97K	89K	3K	3K	n/a
Gross Profit	-97K	-89K	-3K	-3K	n/a
Operating Income	-12.05M	-13.55M	-5.59M	-2.89M	-1.24M
Interest Income	178K	91K	n/a	61K	18K
Pretax Income	-11.28M	-12.34M	-4.04M	-2.83M	-1.22M
Net Income	-10.11M	-11.2M	-2.5M	-2.83M	-1.23M
Selling & General & Admin	4.78M	7.14M	2.5M	393K	337K
Research & Development	7.27M	6.42M	3.08M	2.5M	898K
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	12.05M	13.55M	5.59M	2.89M	1.24M
Interest Expense	550K	15K	1.15M	1K	5K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	12.05M	13.55M	5.59M	2.89M	1.24M
Income Tax	n/a	-1.14M	-1.55M	1K	5K
Shares Outstanding (Basic)	13.64M	11.5M	1.94M	1.94M	1.94M
Shares Outstanding (Diluted)	13.64M	11.5M	1.94M	1.94M	1.94M
EPS (Basic)	-0.83	-0.97	-1.29	-1.46	-0.63
EPS (Diluted)	-0.83	-0.97	-1.29	-1.46	-0.63
EBITDA	-10.63M	-13.38M	-2.88M	-2.83M	-1.25M
EBIT	-10.73M	-12.32M	-2.89M	-2.83M	-1.22M
Depreciation & Amortization	97K	89K	3K	3K	1.24M